Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (UP0) Q2 2024 Earnings Report

0 Followers

CH:UP0 Q2 2024 EPS Results

Actual EPS
-CHF 1.28
Consensus EPS
-CHF 1.40
Beat/Miss
Beat by +CHF 0.12
One Year Ago EPS
-CHF 1.89

CH:UP0 Q2 2024 Revenue Results

Actual Revenue
CHF 123.61M
Expected Revenue
CHF 103.58M
Beat/Miss
Beat by +CHF 20.03M
YoY Revenue Growth
+35.75%

Earnings Announcement Details

Quarter
Q2 2024
Date
08/01/2024
Time
After Close
Conference Call
Thursday, August 1, 2024
CH:UP0 Upcoming Earnings

Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

CH:UP0 Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:UP0 Earnings History

CH:UP0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)1.99--1.08――
Nov 03, 20262026 (Q3)-0.92-0.98-1.5235.91% (+0.55)
Aug 04, 20262026 (Q2)-1.04-0.76-0.9823.08% (+0.23)
May 05, 20262026 (Q1)-1.25-1.55-1.32-17.20% (-0.23)
Feb 12, 20262025 (Q4)-0.92-1.08-1.177.19% (+0.08)
Nov 04, 20252025 (Q3)-1.04-1.52-1.18-29.29% (-0.34)
Aug 05, 20252025 (Q2)-1.09-0.98-1.2823.03% (+0.29)
May 06, 20252025 (Q1)-1.34-1.32-1.7122.66% (+0.39)
Feb 13, 20252024 (Q4)-1.10-1.17-1.288.55% (+0.11)
Nov 05, 20242024 (Q3)-1.25-1.18-1.8737.22% (+0.70)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed